Spring, TX, United States of America

David Swallow

USPTO Granted Patents = 2 

 

 

Average Co-Inventor Count = 9.1

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2016-2023

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: David Swallow: Innovator in Polymer-Drug Conjugate Technologies

Introduction

David Swallow is an accomplished inventor based in Spring, Texas, who has made significant contributions to the field of polymer-drug conjugate technologies. With a total of two patents to his name, his work focuses on developing innovative methods and materials that enhance the efficacy and stability of drug formulations.

Latest Patents

David's latest patents reflect his expertise and dedication to the advancement of pharmaceutical sciences. One of his patents outlines novel alkoxylation methods that introduce a mixed-acid salt of a water-soluble polymer-drug conjugate. This innovation is notable for its stability, exhibiting greater resistance to hydrolytic degradation than classical acid salt or free base forms. The reproducibility of this mixed acid salt demonstrates surprising advantages over non-mixed counterparts, aiding in the effective delivery of therapeutic compounds.

In addition, David has developed a patent concerning the salt form of a multi-arm polymer-drug conjugate. This patent describes a hydrohalide salt of a multi-arm water-soluble polyethylene glycol-drug conjugate, which also showcases enhanced stability and resistance to hydrolysis compared to its free base form. These advancements hold potential for improving drug delivery systems and therapeutic outcomes.

Career Highlights

David Swallow's work is primarily associated with Nektar Therapeutics, a company renowned for its innovative approaches to drug development. His research has contributed to Nektar's mission to transform the way medicines are delivered and utilized, which plays a crucial role in enhancing patient care.

Collaborations

Throughout his career, David has collaborated with skilled professionals in the field, including notable coworkers Antoni Kozlowski and Samuel P. McManus. Their teamwork illustrates the multidisciplinary efforts within Nektar Therapeutics to push the boundaries of pharmaceutical technology and discover new ways to improve drug formulations.

Conclusion

David Swallow stands out as a prominent inventor in the realm of polymer-drug conjugates, demonstrating how innovative methodologies can significantly impact drug stability and effectiveness. With ongoing developments in his field and a commitment to advancing pharmaceutical sciences, David continues to be a key figure to watch within the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…